Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
America Movil
AMX
$69.4B
| $940K | ﹤0.01% |
43,421
+7,263
| +20% | +$158K |
|
|
FOLD
4027
DELISTED
Amicus Therapeutics
FOLD
| $938K | ﹤0.01% |
74,680
-1,863,903
| -96% | -$22.1M |
|
4028
KVH Industries
KVHI
$136M
| $936K | ﹤0.01% |
102,457
-74,127
| -42% | -$747K |
|
4029
CALL
Acumen Pharmaceuticals
ABOS
$211M
| $934K | ﹤0.01% |
+194,100
| New | +$929K |
|
4030
PUT
Prologis
PLD
$134B
| $932K | ﹤0.01% |
7,600
-29,500
| -80% | -$3.63M |
|
4031
Bausch + Lomb
BLCO
$6.13B
| $932K | ﹤0.01% |
46,513
-20,865
| -31% | -$379K |
|
|
SWN
4032
CALL
DELISTED
Southwestern Energy Company
SWN
| $932K | ﹤0.01% |
155,000
-620,000
| -80% | -$3.2M |
|
4033
CALL
Puma Biotechnology
PBYI
$468M
| $931K | ﹤0.01% |
263,800
+15,400
| +6% | +$48K |
|
4034
ALX Oncology
ALXO
$277M
| $931K | ﹤0.01% |
123,933
+71,027
| +134% | +$465K |
|
4035
CALL
nVent Electric
NVT
$24B
| $930K | ﹤0.01% |
+18,000
| New | +$799K |
|
4036
PUT
Pinnacle West Capital
PNW
$11.8B
| $929K | ﹤0.01% |
+11,400
| New | +$909K |
|
4037
Semtech
SMTC
$12.2B
| $927K | ﹤0.01% |
36,420
-263,695
| -88% | -$5.69M |
|
4038
PUT
Cincinnati Financial
CINF
$26.4B
| $925K | ﹤0.01% |
9,500
+600
| +7% | +$62K |
|
4039
HF Sinclair
DINO
$17.7B
| $921K | ﹤0.01% |
20,654
-954,735
| -98% | -$41.6M |
|
4040
Oxford Square Capital
OXSQ
$146M
| $921K | ﹤0.01% |
347,662
+191,352
| +122% | +$561K |
|
4041
PUT
CBRE Group
CBRE
$43.7B
| $920K | ﹤0.01% |
11,400
-20,200
| -64% | -$1.51M |
|
4042
CALL
AGCO
AGCO
$7.94B
| $920K | ﹤0.01% |
+7,000
| New | +$868K |
|
4043
Regional Management Corp
RM
$300M
| $920K | ﹤0.01% |
30,153
+12,722
| +73% | +$349K |
|
4044
Consensus Cloud Solutions
CCSI
$696M
| $919K | ﹤0.01% |
29,646
+13,159
| +80% | +$463K |
|
4045
Biglari Holdings Class A
BH.A
$1.21B
| $916K | ﹤0.01% |
964
-467
| -33% | -$432K |
|
4046
iShares US Medical Devices ETF
IHI
$3.41B
| $914K | ﹤0.01% |
+16,197
| New | +$892K |
|
4047
Telecom Argentina
TEO
$5.63B
| $913K | ﹤0.01% |
+149,969
| New | +$813K |
|
4048
SFL Corp
SFL
$1.72B
| $910K | ﹤0.01% |
97,532
-229,926
| -70% | -$2.08M |
|
|
JWN
4049
DELISTED
Nordstrom
JWN
| $908K | ﹤0.01% |
44,375
-155,353
| -78% | -$2.61M |
|
4050
Citizens
CIA
$194M
| $907K | ﹤0.01% |
376,191
-70,854
| -16% | -$162K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.